|
US2014056967A1
|
|
Vaccines against chlamydial infection
|
|
US2011177082A1
|
|
Compositions and methods for the therapy and diagnosis of ovarian cancer
|
|
JP2009195236A
|
|
Compound for immunotherapy and diagnosis of breast cancer and method for their use
|
|
JP2009142284A
|
|
Composition and method for therapy and diagnosis of prostate cancer
|
|
IL193595D0
|
|
A polypeptide containing an immunogenic portion of a m. tuberculosis antigen, and pharmaceutical compositions containing the same
|
|
JP2008289482A
|
|
Composition and method for therapy and diagnosis of ovarian cancer
|
|
AU2008201853A1
|
|
Compositions and methods for the treatment and diagnosis of breast cancer
|
|
JP2008289472A
|
|
Composition and method for treating and diagnosing breast cancer
|
|
JP2008178413A
|
|
Composition and method for therapy and diagnosis of lung cancer
|
|
US2008213264A1
|
|
Compounds and methods for treatment and diagnosis of chlamydial infection
|
|
AU2007216683A1
|
|
Compositions and methods for therapy and diagnosis of ovarian cancer
|
|
EP2066810A2
|
|
Methods, compositions, and kits for the detection and monitoring of colon cancer
|
|
WO2007120753A2
|
|
Methods, compositions, and kits for the detection and monitoring of bladder cancer
|
|
US2007264651A1
|
|
Methods, compositions, and kits for the detection and monitoring of kidney cancer
|
|
AU2007201253A1
|
|
Compositions and methods for the therapy and diagnosis of breast cancer
|
|
AU2006201363A1
|
|
Compositions for the treatment and diagnosis of breast cancer and methods for their use
|
|
US2006292600A1
|
|
Methods, compositions and kits for the detection and monitoring of lung cancer
|
|
AU2006229968A1
|
|
Vaccines against Chlamydial infection
|
|
US2006252066A1
|
|
Compositions and methods for the therapy and diagnosis of kidney cancer
|
|
AU2006200910A1
|
|
Compositions and methods for the diagnosis and treatment of herpes simplex virus infection
|
